African-Canadian Study of HIV-Infected Adults and a Vaccine for Ebola - ACHIV-Ebola
Clinical trial NCT03031912 · COMPLETED
Trial details
- NCT number
- NCT03031912
- Sponsor
- Canadian Immunization Research Network
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-01
- Primary completion
- 2023-03-03
- Enrollment
- 251
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.